Quarterly report [Sections 13 or 15(d)]

Financial Instruments (Additional Information) (Details)

v3.25.2
Financial Instruments (Additional Information) (Details) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration payable $ 2,586 $ 3,127
Accrued and Other Current Liabilities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Contingent consideration payable $ 700  
Maximum [Member] | Level 3 [Member] | 2025    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
EBITDA earned percentage 1804.00%  
Maximum [Member] | Level 3 [Member] | 2026    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
EBITDA earned percentage 163.00%  
Maximum [Member] | Level 3 [Member] | 2027    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
EBITDA earned percentage 118.00%  
Minimum [Member] | Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Incremental borrowing rate percent 14.20%  
Minimum [Member] | Level 3 [Member] | 2025    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
EBITDA earned percentage 574.00%  
Minimum [Member] | Level 3 [Member] | 2026    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
EBITDA earned percentage 98.00%  
Minimum [Member] | Level 3 [Member] | 2027    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
EBITDA earned percentage 41.00%